Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ind-Swift Laboratories Ltd. Capital/Financing Update 2020

Jan 8, 2020

62552_rns_2020-01-08_3e3939e2-1eb5-4001-8e8b-299978a963cd.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

pursuanttoconversionofOptionallyConvertibleDebentu pursuanttoconversionofOptionallyConvertibleDebentu res(“OCDs”) res(“OCDs”)
PursuanttoRegulation30oftheSEBI(LODR),2015andConvertibleDebentures(‘OCDs”),thisistoinformyouthatmeetingheldtoday,’i.e.8"January,2020hasapproved intermsofpreferentialissueofOptionally theBoardofDirectorsoftheCompanyatitstheallotmentof1,15,17,670Equitysharesof
facevalueofRs.10eachtothefollowingholders ofOCDs:
S.NoName Numberof Shares
1ECSpecialSituationsFund 40,31,184
2EdelweissIndiaSpecialSituationsFund II 61,60,802 -
3EISAFIlOnshoreFund 13,25,684
Total 1,15,17,670

==> picture [206 x 81] intentionally omitted <==